Michigan Alzheimer’s Disease Research Center expert Bruno Giordani, Ph.D., and Michigan State University expert Scott Counts, Ph.D., will present the latest in Alzheimer’s and dementia research in partnership with the Alzheimer’s Association Michigan Chapter on Sept. 23 and 29.
Among other topics, Giordani and Counts will discuss research findings presented at the Alzheimer’s Association International Conference such as a possible correlation between flu and pneumonia vaccinations to lower risk of dementia, a potential blood test for Alzheimer’s, and the launch of a new research study to globally track and understand the long-term impact of exposure to the novel coronavirus on the brain.
The free virtual presentations are designed for caregivers and anyone interested in learning more about dementia research. They will provide up-to-date information on what is currently known about Alzheimer’s disease and offer insight into where future research may be headed.
“We’re thrilled to have such remarkable experts on-hand to educate and inform Michigan residents about the dementia research landscape,” said Jean Barnas, Alzheimer’s Association Michigan Chapter programs services director. “Participants can expect to learn from them more about the biological and neurological processes associated with dementia, their implications for research hypotheses, and promising next steps for clinical studies, such as potential targets for drug-therapies, early detection and prevention.”
Participants can choose to attend one or more of the sessions below.
Wednesday, Sept. 23
Bruno Giordani, Ph.D.
Tuesday, Sept. 29
Scott Counts, Ph.D.
Bruno Giordani, Ph.D.
, serves as the senior director for the Mary A. Rackham Institute in the University of Michigan Rackham Graduate School and as the chief of psychology for the department of psychiatry. He is a tenured professor in the departments of psychiatry, neurology, and psychology, as well as at the School of Nursing at the University of Michigan. He also is associate director of the Michigan Alzheimer’s Disease Research Center and has a longstanding history of connecting with the community to promote a better understanding of Alzheimer’s disease and related conditions.
Dr. Giordani’s research initiatives focus on a cross-cultural perspective on the early assessment of cognitive and behavioral changes associated with medical illness and the interaction of cognition and mobility across the life-span.
Dr. Scott Counts, Ph.D.
, serves as associate professor of translational neuroscience (primary) and family medicine (secondary) at Michigan State University’s Grand Rapids campus. He is also a co-investigator for the Michigan Alzheimer’s Disease Research Center. He previously worked as assistant professor of neurological sciences at Chicago’s Rush University Medical Center.
Dr. Counts’ research seeks to understand how and why certain nerve cells die in the brain in mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. This knowledge may reveal novel targets for therapy.
For more information, visit alz.org/gmc
or contact the Alzheimer’s Association 24/7 Helpline at 800.272.3900.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.